PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Label design may affect risk of medication errors in OR, reports Journal of Patient Safety

Redesigned labels reduce the number of errors in simulated surgical emergency, study finds

2015-03-16
(Press-News.org) March 16, 2015- Special redesigned labels for intravenous (IV) medication bags may help to prevent serious medication errors in the operating room, reports a study in the March issue of the Journal of Patient Safety. The journal is published by Wolters Kluwer. Based on trainee behaviors during OR simulations, "The results of this study provide additional evidence to support the use of opaque, white medication labels and the use of inverted text for highlighting key medication information on the label," writes Jamie L. Estock, MA, of the VA Pittsburgh Healthcare System and colleagues.

Simulations Assess Impact of Medication Labels Designed for Safety The researchers performed a study to explore how one recommended label design for IV medication bags might affect the risk of giving the wrong drug during an OR emergency. In the study, 96 anesthesia trainees (anesthesiologists or nurse-anesthetists) were randomly assigned to participate in simulations of a "realistic, high-stress, clinical situation" using standard or redesigned medication labels.

The redesigned labels were opaque, white, two-sided labels, with "inverted text"--in this case, white letters on a dark background--highlighting key medication information. The standard labels were printed only on one side of the clear medication bags, with smaller text and a more cluttered appearance.

The experiment used a simulated crisis, in which the surgeon called for emergency administration of a volume expander (hetastarch) to a patient in unstable condition. Participating trainees had to quickly select the correct medication from their anesthesia cart.

However, the carts were "incorrectly stocked," with a bag of local anesthetic (lidocaine) placed where hetastarch should have been. This scenario was prompted by a "close call" involving an IV bag of lidocaine that could have been substituted for a bag of hetastarch due to lookalike packaging. The trainees' responses were videotaped to see if the redesigned labels would help them correctly select hetastarch from the anesthesia cart.

Redesigned Labels Reduce the Rate of Medication 'Errors' "The percentage of participants who correctly selected hetastarch from the cart was significantly higher for the redesigned labels than the current labels," Ms Estock and coauthors write. More than 60 percent of trainees correctly chose the hetastarch bag when the redesigned labels were used, compared to about 40 percent with the standard labels. On statistical analysis, the odds of selecting the correct medication were more than twice as high with the redesigned labels.

All of the participants who selected hetastarch from the cart went on to administer hetastarch. Thus, "[T]he redesigned label prevented some potentially catastrophic errors from reaching the simulated patient," Ms Estock and colleagues conclude.

Medication labels are just one of many factors that can contribute to medication errors in complex health care environments. Although medication safety organizations have suggested labeling changes with the goal of reducing error risk, there is little evidence showing that the redesigned labels will improve medication safety in real clinical practice settings.

The new results provide a new piece of evidence that one specific label design for IV bags can reduce the risk of medication errors. The researchers emphasize that their study was in simulation--likely with a higher rate of errors than in the "real world." Ms Estock and colleagues call for further studies to evaluate recommended label redesigns, with adoption of those designs that show "a measurable improvement on medication safety."

INFORMATION:

Click here to read "Label Design Affects Medication Safety in an Operating Room Crisis: A Controlled Simulation Study."

Article: "Label Design Affects Medication Safety in an Operating Room Crisis: A Controlled Simulation Study." (doi: 10.1097/PTS.0000000000000176)

About the Journal of Patient Safety The Journal of Patient Safety is dedicated to presenting research advances and field applications in every area of patient safety. While Journal of Patient Safety has a research emphasis, it also publishes articles describing lessons learned from near-miss incidents, system modifications that are barriers to error, and the impact of regulatory changes on healthcare delivery. It prioritizes articles that translate knowledge to action as healthcare transitions from a volume driven to value driven paradigm...making certain that safety is the core intrinsic property. The mix of research and real-world findings makes Journal of Patient Safety a valuable resource across the breadth of health professions and from bench to bedside.

About Wolters Kluwer Wolters Kluwer is a global leader in professional information services. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance and healthcare rely on Wolters Kluwer's market leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.

Wolters Kluwer reported 2014 annual revenues of €3.7 billion. The group serves customers in over 170 countries, and employs over 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on NYSE Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

For more information about our products and organization, visit http://www.wolterskluwer.com, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on END



ELSE PRESS RELEASES FROM THIS DATE:

Mental health misdiagnosis twice more likely for socially disadvantaged groups

2015-03-16
March 16, 2015 - The shooting of an unarmed teenager in Ferguson, MO, has ignited a global discussion about implicit racial bias. One group of people you might think would be immune from this hidden bias is clinical therapists, people trained to understand the human mind. But a new field study finds that the social identities of patients and their therapists affect the accuracy of the diagnosis: Therapists were twice as likely to misdiagnose mental illness when their patients were members of a disadvantaged, compared to an advantaged, group. In her own practice, Ora Nakash, ...

Genetics: No evidence of role in racial mortality gap

2015-03-16
There is still no evidence of genetic difference between blacks and whites to account for the health disparities in cardiovascular disease (CVD), according to a new study by McGill University researchers. Published in the American Journal of Epidemiology, the researchers suggest that after a decade of genetic studies, factors such as lifestyle, education and socio-economics - not genetics - are more promising avenues to understanding racial health disparities. The researchers focused on cardiovascular disease, the largest contributor to the racial mortality gap, and ...

Penn vet team points to new colon cancer culprit

Penn vet team points to new colon cancer culprit
2015-03-16
Colon cancer is a heavily studied disease -- and for good reason. It is one of the leading causes of cancer-related deaths worldwide, and its numbers are on the rise, from 500,00 deaths in 1990 to 700,000 in 2010. This growth comes despite scientists' ever-increasing knowledge of the genetic mutations that initiate and drive this disease. Now, a team of researchers from the University of Pennsylvania has found evidence of a new culprit in the disease, a protein called MSI2. Their findings provide a new target for potential therapeutic intervention in colorectal cancer ...

New clues from the dawn of the solar system

New clues from the dawn of the solar system
2015-03-16
A research group in the UA Lunar and Planetary Laboratory has found evidence in meteorites that hint at the discovery of a previously unknown region within the swirling disk of dust and gas known as the protoplanetary disk - which gave rise to the planets in our solar system. Led by Kelly Miller, a doctoral student in the lab of Dante Lauretta, the principal investigator of NASA's OSIRIS-REx mission, the team has found evidence of minerals within meteorites that formed in an environment that was enhanced in oxygen and sulfur and date from a time before the particles stuck ...

New research finds oceanic microbes behave in a synchrony across ocean basins

New research finds oceanic microbes behave in a synchrony across ocean basins
2015-03-16
Researchers from the University of Hawai'i - M?noa (UHM) and colleagues found that microbial communities in different regions of the Pacific Ocean displayed strikingly similar daily rhythms in their metabolism despite inhabiting extremely different habitats - the nutrient-rich waters off California and the nutrient-poor waters north of Hawai'i. Furthermore, in each location, the dominant photoautotrophs - light-loving bacteria that need solar energy to help them photosynthesize food from inorganic substances - appear to initiate a cascade effect wherein the other major ...

American College of Cardiology's 64th Annual Scientific Session PM tip sheet for March 15, 2015

2015-03-16
The studies below will be presented at the American College of Cardiology's 64th Annual Scientific Session on Sunday, March 15. 1. Survey Suggests Cardiologists May Not Be Prepared to Counsel Patients on Heart Healthy Diets Even though most doctors believe diet is important in preventing and managing cardiovascular disease, there are major gaps in their knowledge and, in turn, efforts to educate patients about heart healthy diets may be falling short, according to a recent survey of 236 cardiologists and internal medicine physicians and trainees at a large tertiary ...

Bendavia does not reduce scarring from angioplasty after heart attack

2015-03-16
Patients who received the new drug Bendavia before undergoing angioplasty or receiving a stent to clear blocked arteries after a heart attack showed no significant reduction in scarring as compared to patients given a placebo, according to a study presented at the American College of Cardiology's 64th Annual Scientific Session. The study is the first randomized, controlled trial of Bendavia, a drug designed to reduce the extent of tissue damage in the heart through a new approach that targets mitochondria in the cells. Although patients receiving the drug showed a 10 ...

Novel anti-clotting therapy in halted trial no better than existing agents

2015-03-16
SAN DIEGO (March 15, 2015) -- A novel therapy that would allow doctors to turn the body's blood-clotting ability off and on in a more controlled way was about as effective as established anticoagulants in patients undergoing angioplasty but was associated with higher rates of moderate to severe bleeding, according to an analysis of data from a terminated Phase III trial presented at the American College of Cardiology's 64th Annual Scientific Session. The study was officially halted in August due to an excess of severe allergic reactions, so authors caution that the data ...

CT scans appear to dramatically improve diagnosis of heart disease

2015-03-16
SAN DIEGO (March 15, 2015) -- Use of computed tomography coronary angiography, which provides 3-D images of the heart, coupled with standard care allows doctors to more accurately diagnose coronary artery disease in patients presenting with chest pain, therefore, leading to more appropriate follow-up testing and treatments, according to research presented at the American College of Cardiology's 64th Annual Scientific Session. Data also showed a trend toward a lower incidence of heart attacks among the group receiving the tests, known as CT scans, compared to usual care. ...

After 1 year, patients on new drug fare better than standard therapy

2015-03-16
SAN DIEGO (March 15, 2015) -- Patients taking evolocumab--an investigational therapy previously shown to dramatically lower "bad" cholesterol--were half as likely to die, suffer a heart attack or stroke, be hospitalized or need a procedure to open blocked arteries compared with those who received standard care, according to research presented at the American College of Cardiology's 64th Annual Scientific Session in San Diego. In this open-label study, the rate of cardiovascular events was 2.18 percent after one year in the standard of care group, most of whom were on ...

LAST 30 PRESS RELEASES:

Reality check: making indoor smartphone-based augmented reality work

Overthinking what you said? It’s your ‘lizard brain’ talking to newer, advanced parts of your brain

Black men — including transit workers — are targets for aggression on public transportation, study shows

Troubling spike in severe pregnancy-related complications for all ages in Illinois

Alcohol use identified by UTHealth Houston researchers as most common predictor of escalated cannabis vaping among youths in Texas

Need a landing pad for helicopter parenting? Frame tasks as learning

New MUSC Hollings Cancer Center research shows how Golgi stress affects T-cells' tumor-fighting ability

#16to365: New resources for year-round activism to end gender-based violence and strengthen bodily autonomy for all

Earliest fish-trapping facility in Central America discovered in Maya lowlands

São Paulo to host School on Disordered Systems

New insights into sleep uncover key mechanisms related to cognitive function

USC announces strategic collaboration with Autobahn Labs to accelerate drug discovery

Detroit health professionals urge the community to act and address the dangers of antimicrobial resistance

3D-printing advance mitigates three defects simultaneously for failure-free metal parts 

Ancient hot water on Mars points to habitable past: Curtin study

In Patagonia, more snow could protect glaciers from melt — but only if we curb greenhouse gas emissions soon

Simplicity is key to understanding and achieving goals

Caste differentiation in ants

Nutrition that aligns with guidelines during pregnancy may be associated with better infant growth outcomes, NIH study finds

New technology points to unexpected uses for snoRNA

Racial and ethnic variation in survival in early-onset colorectal cancer

Disparities by race and urbanicity in online health care facility reviews

Exploring factors affecting workers' acquisition of exercise habits using machine learning approaches

Nano-patterned copper oxide sensor for ultra-low hydrogen detection

Maintaining bridge safer; Digital sensing-based monitoring system

A novel approach for the composition design of high-entropy fluorite oxides with low thermal conductivity

A groundbreaking new approach to treating chronic abdominal pain

ECOG-ACRIN appoints seven researchers to scientific committee leadership positions

New model of neuronal circuit provides insight on eye movement

Cooking up a breakthrough: Penn engineers refine lipid nanoparticles for better mRNA therapies

[Press-News.org] Label design may affect risk of medication errors in OR, reports Journal of Patient Safety
Redesigned labels reduce the number of errors in simulated surgical emergency, study finds